Related Experiment Videos
Managing HIV. Part 4: Primary therapy. 4.2 Immune-based therapy for HIV infection
E M Benson1, M A French, R T Schooley
1Department of Immunopathology, Institute for Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW Australia.
The Medical Journal of Australia
|March 4, 1996
Abstract:
Immune-based therapy is in its infancy and to date no therapies are licensed in Australia. A number of the reagents are reaching phase III clinical trials and may be available within two years. Patient and physician interest is high because antiretroviral agents have not as yet had a significant impact on survival.